Burden of fungal diseases in Egypt | Author : Sherif M. Zaki | Abstract | Full Text | Abstract :Fungal diseases cause 1.5 million deaths
and cause cutaneous infections to billions of
people worldwide every year (Vos et al., 2012;
GAFFI. 2015).
Egypt is the highest populated country in
the Middle East and North Africa region. Due to
the fact that many risk groups of patients exist in
Egypt, Egyptians suffer from serious fungal
diseases annually. Zaki and Denning, (2017)
reported the estimation of the total burden of
serious fungal diseases in Egypt and concluded
that about 1,649,686 (2%) of Egyptians suffer
from serious fungal diseases annually. |
| Antibacterial potency of garlic extract against certain skin pathogenic bacteria | Author : Dadile M. Abdulrahman, Abdullahi M. Daskum, Kura M. Abdulrahim, Abubakar M. Dadile , Hajja Amma | Abstract | Full Text | Abstract :The antibacterial potency of garlic extract (Allium sativum) against gram positive and gram negative
skin pathogenic bacteria including; Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus
pyogenes, and Pseudomonas aeruginosa were studied using agar well diffusion and broth dilution assays.
Agar well diffusion assay for aqueous garlic extract (AGE) was characterized with zones of inhibition
ranging from 4.40 – 3.80cm, 4.13 - 3.57cm, 3.40 – 2.67cm for S. aureus, S. epidermidis and Strep.
pyogenes, respectively, however, Ps. aeruginosa had lesser zone of inhibition ranging from 2.32 –
1.55cm. Studying the antibacterial potency of AGE against the selected isolates, revealed that it is
affected by temperature of storage. Current results showed that storage of AGE at low temperature of -
20oC, does not affect its potency, however, its potency was slightly lost at high temperatures above 37oC.
The broth dilution test was performed to investigate the Minimum inhibitory concentration (MIC) and
Minimum bactericidal concentration (MBC) of the AGE against the bacterial isolates at 37oC.
Investigating the activity of AGE loaded on Gel dressing revealed that it can have potency when applied
on patients with Staphylococcal skin infections. Findings from this study encourage and support the use
of AGE in treating bacterial skin infections especially in developing countries like Africa, as it is
available, economic and have no side effects. |
|
|